PASCAL photocoagulation system: pattern scan laser

PASCAL photocoagulation system: pattern scan laser

¿What is PASCAL photocoagulation system?

PASCAL photocoagulator (pattern scan laser) is a fully integrated photocoagulation laser scan system designed for the treatment of diabetic retinopathy through a beam or a particular pattern array of up to 25 points.

Designed to stablish a new standard in the treatment of retina diseases, Pascal has been used to treat thousands of patients around the world.

It also includes an intuitive touch screen and an advance optical slit lamp.


What does PASCAL photocoagulator do?

PASCAL photocoagulation system is used to treat a variety of retina diseases such as diabetic retinopathy, age-related macular degeneration and retinal vascular occlusion disease.


How does PASCAL photocoagulation method work?

PASCAL technology deploys a semiautomatic model generation method using short laser beam lengths of 20 milliseconds (five times shorter than conventional systems).


What are the advantages of PASCAL method?

PASCAL photocoagulation method is compatible with standard protocols. It is based on clinical trials.

  • Performance: higher efficiency. Reduced treatment time.
  • Increased patient comfort: A much more comfortable therapeutic experience, which could lead to a higher patient compliance.
  • Advanced precision: macular grid treatment provides an enhanced dosimetry control and security margin when compared to single beam treatments.
  • Reproducibility: predictable impact size with consistent patterns which lead to more precise treatment comparisons and higher compliance with specific data treatment protocols.

What are the clinical indications for PASCAL?

PASCAL photocoagulator is the best option for ocular diseases treatment and for the use of anterior and posterior segments photocoagulation, which includes:

  • Focal and retinal photocoagulation, grid photocoagulation for vascular and retinal and choroid structural abnormalities.
  • Proliferative and non-proliferative diabetic retinopathy 
  • Choroidal neovascularization
  • Central retinal vein occlusion 
  • Reticular degeneration
  • Iridotomy, iridectomy and trabeculoplasty in closing angle and open-angle glaucoma

 

Do you have any questions?

Contact us or request an appointment with one of our specialists.

Visit us at:

ICR Pau Alcover

C. Pau Alcover 67
08017 Barcelona See map

ICR Ganduxer Headquarters

c/Ganduxer,117
08022 Barcelona See map

ICR Terrassa

77, Del Nord St.
08221 Terrassa See map

ICR Service at Clínica Ntra. Sra. del Remei

c/ de l'Escorial,148
08024 Barcelona See map

Clínica Bonanova Surgical Center

Passeig Bonanova, 22
08022 Barcelona See map

Clinica Bonanova Tests and Treatments

c/ Mandri, 63
08022 Barcelona See map

ICR Pau Alcover

Telephone number (+34) 93 378 23 19

Opening hours:
Monday to Friday from 8 am to 8 pm. Saturday from 8 am to 2 pm.

How to get there More information

ICR Ganduxer Headquarters

Telephone number 93 254 79 20
Emergencies phone number: 93 418 72 27

Opening hours:
Monday to Friday 8 a.m. to 8 p.m.
Saturdays 9 a.m. to 2 p.m.

How to get there More information

ICR Terrassa

Telephone number +34 93 736 34 40

Opening hours:
Monday to Friday from 8:30 a.m. to 2 p.m. and 3 p.m. to 8 p.m.
The center will be closed from August 3 to 23, both included. If you have an emergency, you can contact ICR Barcelona (C / Ganduxer, 117), where we have a 24-hour emergency service.

How to get there More information

ICR Service at Clínica Ntra. Sra. del Remei

Telephone number 902 10 10 50

Opening hours:
Every day from 3 p.m. to 8 p.m. and Friday mornings from 10 a.m. to 2 p.m.

How to get there More information

Clínica Bonanova Surgical Center

Telephone number 934 34 09 25

Opening hours:
Monday to Friday from 7:30 a.m. to 8:30 p.m.

How to get there More information

Clinica Bonanova Tests and Treatments

How to get there More information

This website uses cookies in order to collect statistical information regarding navigation. If you keep on surfing this website, it shall be deemed to have acknowledged its use. More information.